Magnetic Beads Electrochemical Biosensor miRNA Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods face challenges in accurately and reliably detecting and quantifying microRNAs (miRNAs) in clinical samples, such as FFPE sections and blood serum, due to their complexity and scarcity, requiring rapid, sensitive, and specific techniques.
Innovation Solution
A magnetic beads-based electrochemical sensor method involving homogeneous hybridization, capture of DNA/RNA duplexes by antibody-modified magnetic particles, enzymatic labeling, and electrochemical detection on screen-printed carbon electrodes, allowing for rapid (less than 75 minutes) and highly specific and sensitive detection of miRNAs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods are used for microRNAs in clinical samples, then the detection process is simpler, but the sensitivity and reliability are insufficient for complex and scarce clinical samples
Solution Approach 1:
The detection method is divided into distinct functional modules: magnetic beads for capture, electrochemical sensor for detection, and specific antibody-probe complexes for target recognition. This segmentation allows each component to be optimized independently while maintaining overall system sensitivity and reliability.
Solution Approach 2:
Magnetic beads serve as intermediaries between the complex clinical sample and the electrochemical sensor. They concentrate and immobilize target microRNAs through antibody-probe complexes, enabling sensitive detection while simplifying the interface between sample and detector.
2Productivity
If rapid detection is implemented (less than 75 minutes), then the productivity increases, but the measurement precision may be compromised
Solution Approach 1:
Magnetic beads are pre-modified with specific antibodies and probe complexes before detection. This preliminary preparation enables rapid capture and concentration of target microRNAs during the detection process, achieving both speed and accuracy without compromising measurement precision.
Solution Approach 2:
The method replaces time-consuming mechanical separation and purification steps with magnetic field-based capture and electrochemical detection. This substitution maintains high measurement precision while dramatically reducing detection time to under 75 minutes.
3Measurement precision
If high sensitivity detection is achieved (detection limit 2.4 pM), then the measurement precision improves, but the device complexity increases
Solution Approach 1:
The electrochemical sensor utilizes a screen-printed carbon electrode with porous or high-surface-area structure that enhances signal generation. This material property enables ultra-sensitive detection at 2.4 pM limit while maintaining a relatively simple device architecture suitable for high-throughput applications.
4Productivity
If automated high throughput detection is implemented (up to 30 sensors per day), then the productivity increases, but the ease of operation may be reduced
Solution Approach 1:
The magnetic beads-based electrochemical sensor system is designed with universal components and standardized protocols that enable automated high-throughput operation. The same reagents and procedures can be applied across multiple sensors daily, facilitating automation while maintaining ease of operation through consistency and repeatability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables reliable and reproducible detection and quantification of miRNAs in clinical samples with a detection limit of 2.4 pM, suitable for complex specimens, and can be automated for high throughput, demonstrating its effectiveness in clinical diagnostics.
Implementation Method 1
capture of the resultant DNA/RNA, DNA/DNA or RNA/RNA duplex by an antibody-modified magnetic particle, preferably MBs, in solution
Implementation Method 2
electrochemical detection of the modified-magnetic particles on an electrochemical sensor, preferably on screen-printed carbon electrodes (SPCEs)
Data Source
Figure 1a~1c
Figure 2~3
Figure 4a~4b
AI summary
The present invention is generally directed to methods for detecting and/or quantifying miRNA, RNA or DNA molecules of interest in at least one isolated biological sample. Basically the general procedure followed by the methods of the present invention involve four main steps: (i) homogeneous hybridization of the synthetic DNA or RNA probe and the target miRNA, RNA or DNA molecule of interest; (ii) capture of the resultant DNA/RNA, DNA/DNA or RNA/RNA duplex by the antibody-modified magnetic particles, preferably MBs, in solution; (iii) enzymatic labeling of the biotinylated DNA/RNA, DNA/DNA or RNA/RNA duplex captured onto the antibody-modified magnetic particles, preferably MBs and (iv) electrochemical detection of the modified-magnetic particles on an electrochemical sensor, preferably on screen-printed carbon electrodes (SPCEs).